Your browser doesn't support javascript.
loading
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results.
Popov, Alexander; Henze, Guenter; Roumiantseva, Julia; Budanov, Oleg; Belevtsev, Mikhail; Verzhbitskaya, Tatiana; Boyakova, Elena; Movchan, Liudmila; Tsaur, Grigory; Fadeeva, Maria; Lagoyko, Svetlana; Zharikova, Liudmila; Miakova, Natalia; Litvinov, Dmitry; Khlebnikova, Olga; Streneva, Olga; Stolyarova, Elena; Ponomareva, Natalia; Novichkova, Galina; Fechina, Larisa; Aleinikova, Olga; Karachunskiy, Alexander.
Afiliación
  • Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. uralcytometry@gmail.com.
  • Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Verzhbitskaya T; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Boyakova E; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Movchan L; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Tsaur G; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation.
  • Fadeeva M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Lagoyko S; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Zharikova L; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Khlebnikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Streneva O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Stolyarova E; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Ponomareva N; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Novichkova G; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Fechina L; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Aleinikova O; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Karachunskiy A; Republican Children's Hospital, Moscow, Russian Federation.
Leukemia ; 36(5): 1382-1385, 2022 05.
Article en En | MEDLINE | ID: mdl-35322171
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido